Literature DB >> 18929420

Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis.

Gerlinde Teuber1, Arne Schäfer, Jasmin Rimpel, Kathrin Paul, Christian Keicher, Michael Scheurlen, Stefan Zeuzem, Michael R Kraus.   

Abstract

BACKGROUND/AIMS: Health-related quality of life (HRQoL) is impaired in patients with chronic hepatitis C. We investigated HRQoL and fatigue in patients with chronic hepatitis C virus (HCV) infection in relation to the degree of fibrosis and inflammation, and controlled for the influence of relevant demographic and medical variables.
METHODS: We conducted a cross-sectional two-center study including 215 outpatients with chronic hepatitis C applying the Short-Form Health Survey (SF-36) and the Fatigue Impact Scale (FIS-D). The contribution to the variability of these psychometric scores was evaluated for the degree of fibrosis as well as viremia, gender, age, mode of transmission, genotype, and ALT.
RESULTS: There was a strong negative association between the degree of liver fibrosis and the physical SF-36 summary score (p=0.016). This was independent of the covariate age, also significantly predicting physical HRQoL (p=0.001). The absolute FIS score was significantly increased in patients with advanced fibrosis (p=0.043). In females, mental SF-36 summary score (p=0.007) and fatigue (p=0.017) were significantly more impaired.
CONCLUSIONS: Our study suggests a significant association of physical aspects of HRQoL and fatigue with the extent of fibrosis. Fibrosis stage should be considered for the identification and management of HCV patients at risk for reduced physical HRQoL.

Entities:  

Mesh:

Year:  2008        PMID: 18929420     DOI: 10.1016/j.jhep.2008.07.025

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  21 in total

1.  Long-term quality of life of liver transplant recipients beyond 60 years of age.

Authors:  G Werkgartner; D Wagner; S Manhal; A Fahrleitner-Pammer; H J Mischinger; M Wagner; R Grgic; R E Roller; D Kniepeiss
Journal:  Age (Dordr)       Date:  2013-03-26

2.  Health-related quality of life in Greek chronic hepatitis C patients during pegylated interferon and ribavirin treatment.

Authors:  E Sinakos; E Gigi; T Lalla; A-L Bellou; A Sykja; E Orphanou; E Vrettou; V Tsapas; M Raptopoulou
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

3.  Evaluation of the health-related quality of life using the 36-item short form health survey in patients with chronic hepatitis C receiving pegylated interferon/ribavirin/telaprevir triple treatment.

Authors:  Mitsuyuki Suzuki; Toru Ishikawa; Ai Sakuma; Satoshi Abe; Hiroko Abe; Fujiko Koyama; Tomomi Nakano; Aya Ueki; Hirohito Noguchi; Erina Hasegawa; Shiori Yamagata; Miki Kobayashi; Kazutaka Ohashi; Hiroshi Hirosawa; Takako Fukazawa; Yuka Maruyama; Toshiaki Yoshida
Journal:  Exp Ther Med       Date:  2016-10-05       Impact factor: 2.447

4.  Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.

Authors:  Zobair M Younossi; Maria Stepanova; Mark Sulkowski; Graham R Foster; Nancy Reau; Alessandra Mangia; Keyur Patel; Norbert Bräu; Stuart K Roberts; Nezam Afdhal; Fatema Nader; Linda Henry; Sharon Hunt
Journal:  Clin Infect Dis       Date:  2016-07-20       Impact factor: 9.079

5.  Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals.

Authors:  Jennifer Gillis; Curtis Cooper; Sean Rourke; Sergio Rueda; Kelly O'Brien; Evan Collins; Anita Rachlis; Trevor A Hart; Janet Raboud
Journal:  Qual Life Res       Date:  2012-10-17       Impact factor: 4.147

6.  Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.

Authors:  K K Snow; H L Bonkovsky; R J Fontana; H-Y Kim; R K Sterling; A M Di Bisceglie; T R Morgan; J L Dienstag; M G Ghany
Journal:  Aliment Pharmacol Ther       Date:  2010-01-12       Impact factor: 8.171

7.  Altered quality of life in the early stages of chronic hepatitis C is due to the virus itself.

Authors:  Edna Strauss; Francisco Augusto Porto-Ferreira; Cesar de Almeida-Neto; Maria Cristina Dias Teixeira
Journal:  Clin Res Hepatol Gastroenterol       Date:  2013-11-14       Impact factor: 2.947

8.  Assessment of factors associated with the quality of life of patients living with HIV/HCV co-infection.

Authors:  Marco Pereira; Renata Fialho
Journal:  J Behav Med       Date:  2016-08-09

9.  Impairment of health-related quality of life in patients with chronic hepatitis C is associated with insulin resistance.

Authors:  Takuya Kuwashiro; Toshihiko Mizuta; Yasunori Kawaguchi; Shinji Iwane; Hirokazu Takahashi; Noriko Oza; Satoshi Oeda; Hiroshi Isoda; Yuichiro Eguchi; Iwata Ozaki; Keizo Anzai; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

10.  Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis.

Authors:  Donna M Evon; Hsing-Hua S Lin; Mandana Khalili; Robert J Fontana; Colina Yim; Abdus S Wahed; Michael W Fried; Jay H Hoofnagle
Journal:  Aliment Pharmacol Ther       Date:  2020-01-14       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.